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Miniabstract :
The results obtained in 301 patients with pseudomyxoma peritonei treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy in 18
French-speaking centers confirms good results and that these procedures should be recommended in specialized centers.
STRUCTURED ABSTRACT Objective :
To analyze a large series of patients with pseudomyxoma peritonei (PMP) treated with cytoreductive surgery associated with perioperative intraperitoneal chemotherapy (PIC) in 18 French-speaking centers.
Patients and methods:
From March 1993 to December 2007, 301 patients with diffuse PMP were treated by cytoreductive surgery with PIC. Complete cytoreductive surgery was achieved in 219 patients (73%), and hyperthermic intraperitoneal chemotherapy (HIPEC) was performed in 255 (85%), mainly during the latter period of the study.
Results:
Postoperative mortality and morbidity were 4.4% and 40%, respectively. The mean follow-up was 88 months. The 5-year overall and disease-free survival rates were 73%% and 56%, respectively. The multivariate analysis identified 5 prognostic factors : the extent of peritoneal seeding (p=0.004), the center (p=0.0004), the pathologic grade (p=0.03), gender (p=0.02), and the use of HIPEC (p=0.04). When only the 206 patients with complete cytoreductive surgery were considered, the extent of peritoneal seeding was the only significant prognostic factor (p=0.004). Pseudomyxoma peritonei (PMP) is a clinico-pathologic entity characterized by the production of mucinous ascites (1,2) and mostly originates from appendiceal epithelial neoplasms. The tumor grows, obstructing the narrow lumen of the appendix and subsequently leading to appendiceal perforation (1, 2) . Then neoplastic cells progressively and slowly colonize the peritoneal cavity and copious mucin production builds up in the peritoneal cavity. Recently, pathologic enteric bacteria were shown to be present in all specimens and their density was correlated with the prognosis (3).
Conclusion:
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Appendix tumors causing PMP range from a benign pathologic appearance (disseminated peritoneal adenomucinosis or DPAM), to malignant pathologic findings (peritoneal mucinous carcinomatosis or PMCA), with some intermediate pathologic grades (4) . Clinically, this syndrome ranges from early PMP fortuitously discovered on imaging or during a laparotomy performed for another reason, to advanced cases with a distended abdomen, occlusive syndrome and starvation.
The conventional treatment of PMP is surgical debulking repeated, as necessary to alleviate pressure effects (5, 6) . However, this treatment is palliative, leaving visible or occult disease in the peritoneal cavity. Repeated debulking surgeries become ever more difficult due to progressively thickened intra-abdominal adhesions (7) .
A combination of cytoreductive surgery (CRS) with perioperative intraperitoneal chemotherapy (PIC) was proposed by Sugarbaker (8) . The rationale behind this strategy was to resect visible disease and any occult residual disease would be treated with a high concentration of chemotherapy and hyperthermia which mutually potentiate one another's effects (9, 10) . Fifteen years and 600 publications later (7), a systematic review of this novel treatment concluded that this combined approach was very probably superior to conventional therapy, even in the absence of controlled
randomized trials, and even with evidence from only five series of more than 100 cases (11) (12) (13) (14) (15) (16) . Each series reported the experience of only one team with various experiences, and there was no multicentric series reflecting "reality". This study aimed to collect patients with PMP treated with this combined approach in 18 different French-speaking centers, to analyze morbidity, mortality and survival results, and to identify the main prognostic factors for better patient selection.
Patients and methods
Patient Population
The AFC (Association Française de Chirurgie) conducted a multicentric retrospective study in French (n=20), Belgian (n=2), Canadian (Quebec, n=2) and Swiss (n=1) centers. Exclusion criteria were tumors originating from the colon, small bowel and appendiceal adenocarcinoma without a predominant mucinous component.
Treatment
Resection of PMP obeyed principles described elsewhere (17) . In short, peritonectomy procedures which included a total anterior and lateral parietal peritonectomy, omentectomy and splenectomy, right and left sub-phrenic peritonectomy, pelvic peritonectomy and lesser omentectomy and cholecystectomy with stripping of the omental bursa were performed exclusively in the macroscopically pathologic areas.
More or less extended resections of the colon, rectum, small-bowel and stomach were associated, if invaded by PMP. Intraperitoneal chemotherapy was delivered immediately after cytoreductive surgery. EPIC was performed from day 1 to day 5 after surgery, and was used during the early period of this retrospective study. HIPEC was performed with an opened abdominal cavity (Coliseum technique), or a closed one and was used during the major second period of the study.
Data Forms
A standard data form was created to retrieve information on the primary colorectal tumor, on the status of the patient prior to the combined procedure, and on previous treatment with systemic chemotherapy. The extent of PC is assessed through intraoperative exploration using the Peritoneal Cancer Index (PCI) which scores from 0 to 3 each of the 13 defined areas of the abdominal cavity, and therefore ranges from 1 to 39. Four PCI subgroups were arbitrarily defined for the analysis : 1 to 6, 7 to 12, 13 Data recorded included the most recent follow-up information, the status of the patient (alive with disease, alive without disease, died with disease, died without disease), and the site of the initial recurrence.
Statistical Analysis
The descriptive analyses of the patients included in the registry, as well as the survival analyses were performed on a per-patient basis (one record per patient). However, all procedures were considered for the analyses of postoperative morbi-mortality events (death or major complications occurring within 30 days after surgery).
Categorical variables were described in terms of frequency and percentages. The distributions of continuous variables were described with the mean, standard error, median, 1 st and 3 rd quartiles. Patient, disease and treatment characteristics were correlated with postoperative morbi-mortality events using univariate and multivariate logistic regression models, adjusted on centers, because of their strong prognostic influence.
The analysis of long-term mortality censored information after the cut-off date of December 31 st 2007 since an active enquiry was performed in all centers to collect the status (dead/alive) of the patients at that date. The analysis of total mortality considered the interval from the first procedure to the date of death, the date of the M A N U S C R I P T PMP originated from the appendix in 91% of the cases (ovary in 7%, and the origin was unknown in 2%). The circumstances leading to the discovery of PMP were : unexplained ascites leading to laparoscopy or laparotomy ( (32%), abdominal pain (27%), increasing abdominal girth (15%), on imaging performed for an another reason (15%), deterioration of general status (5%), wound hernia (4%), and appendicitis (2%).
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Treatment Modalities
The mean peritoneal index was 18. 
Mortality and Morbidity
Thirteen patients (4.4%) had died postoperatively. The causes of death were septic shock (9 patients) linked to abdominal infection, respiratory complications (4 patients), hematological toxicity (2 patients), pulmonary embolism (1 patient), and acute renal insufficiency (1 patient).
Grade 3-4 complications had occurred in 119 patients (40%), and 17.5% (n=52) of all patients had been re-operated on; 8% (n=24) had a digestive fistula, 9% (n=27) a intraperitoneal abscess, 13% (n=38) hemorrhage, 14% (n=42) a pulmonary infection, and M A N U S C R I P T The logistic regression analysis of factors which significantly increased the risk of mortality and morbidity identified two main factors, the peritoneal index (p=0.002, correlated with the extent and duration of surgery), and the presence of a high pathologic grade (PMCA) (p= 0.03).
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Survival
With a mean follow-up of 88.4 months (1 st -3 rd quartile: 28 -125, median: 73), the overall 1-year, 3-year, and 5-year survival rates were respectively 89.4%, 84.8% and 72.6% (figure 1). The 10-year survival rate was 54.8%. Median survival had not yet been reached, but it will be longer than 100 months. The disease-free survival (DFS) rate was 56% at 5 years (figure 1) and the median duration of DFS was 78 months.
There was a strong center effect (p=0.004) that justified an analysis of the impact of other prognostic factors adjusted on centers (figure 2). Figure 2 shows 7 curves corresponding to the six centers which treated at least 10 patients and one curve (the lowest one) for the 11 remaining centers (which treated fewer than 10 patients per center).
In the univariate analysis (table 1), age did not exert an impact on survival unlike gender (p=0.02, in favor of females), the extent of peritoneal seeding (p<0.001), the completeness of CRS (p<0.001), the pathologic grade (p<0.001) and the presence of invaded lymph nodes (p<0.001). Two other prognostic factors must be underlined:
HIPEC seemed more efficient than EPIC (p=0.001) and the results were different M A N U S C R I P T
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according to the centers (p=0.0004). The prognosis was worse (p=0.01) for patients who had received systemic chemotherapy (because it was given in advanced and high-grade cases).
The multivariate analysis identified five factors with an independent influence on survival (table 2) . First, the center effect (p<0.01), second, the extent of peritoneal seeding (p=0.004) (figure 3) with a significant decline in survival when the peritoneal index was greater than 20. This index was strongly correlated with the completeness of the CRS : CCR1 and CCR-2 were only observed when the peritoneal index was high.
Thirdly, the pathologic grade (p=0.03) was a poor prognostic factor for PMCA. No significant difference in survival was found between DPAM and intermediate grades.
The other two factors were gender (p=0.02) in favor of females, and the use of HIPEC rather then EPIC (p=0.04).
Multivariate analysis of disease-free survival identified two significant factors: the extent of the peritoneal seeding (p<0.001) (strongly correlated with the CCR-status), and the center's experience (p=0.006).
In the group of 206 patients with a CCR-0 resection, the 5-year and 10-year survival rates were 84% was 61% respectively. It is noteworthy that two factors became nonsignificant in the univariate analysis : gender and the pathologic grade. Only one factor continued to exert a prognostic impact : the extent of peritoneal seeding (p=0.004), while HIPEC was marginally better (p=0.07) than EPIC.
Discussion
This Moreover, a mortality rate of 4% and a morbidity rate of 40% for this combined approach are the sort of rates that would be obtained with any kind of complex oncologic surgery such as oesophagectomy or duodeno-pancreatectomy. These rates are therefore acceptable face to benefits for overall and disease-free survival. period. The 3% and 12% disease-free survival rates are well below the 56% rate we observed in our series. Sugarbaker and Zoetmulder also reported higher rates, 47% and 61%, respectively. All these results are probably due to the superiority of the combined over the conventional approach. In France, this combined approach has become the gold standard treatment when feasible (18) .
Prognostic factors. The multivariate analysis of our series identified four significant and independent prognostic factors, adjusted on centers: the extent of the disease, the pathologic grade, gender, and the use of hyperthermia. One of these factors, namely the extent of the disease, was not identified in the five earlier series of more than 1OO patients treated with the combined approach. In contrast, the completeness of cytoreduction was statistically significant in three (12, 14, 16) . The pathologic grade was not retained in three series (12) (13) (14) (15) , but selected in two (13, 16) Second, the extent of peritoneal seeding has a potent prognostic impact, even if this impact is probably lower than for patients with colorectal peritoneal carcinomatosis (18) (19) (20) (21) . In our series, the 5-year survival rate was only 57% for patients with a peritoneal index exceeding 19, whereas it was 83% for the other patients. We also established that the completeness of cytoreduction was strongly correlated with the disease extent (peritoneal cancer index), and also with the pathologic grades (data not shown). Finally, extensive PMP with high pathologic grades are the most frequently incompletely resected lesions and mainly in inexperienced centers.
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Third, the pathologic grade had a significant prognostic impact on the whole series, but it disappeared when only the 206 patients with a complete CCR-0 resection were considered. Thus complete cytoreductive surgery is able to reduce the negative prognostic impact of the pathologic grade as previously pointed out by Elias et al. (15) .
Fourth, survival was better among female patients in the whole series, but gender was not statistically significant when only CCR-0 patients were taken into account. Thus, male patients more frequently presented with extended and incompletely resectable PMP than female patients.
Fifth, survival results were better with HIPEC than with EPIC. Glehen et al. (23) already reported the superiority of HIPEC over EPIC in a retrospective study evaluating patients treated with incomplete CRS. Our results could stem from a bias because EPIC was mainly used during the earlier period of the study. Although experimental studies are also in favor of the use of hyperthermia (24), its benefit should be confirmed in a prospective study.
Finally, it is noteworthy that the extent of peritoneal seeding was the only prognostic factor identified in the multivariate analysis in the group of patients with a CCR-0 resection.
In conclusion, this multicentric study of 301 patients with PMP confirms the promising results reported earlier by Sugarbaker and a few other experienced teams using the 
